基于MGRN1的生物标志物组合准确预测了黑色素瘤患者的生存率
José Sánchez-Beltrán1,2, Javier Soler Díaz1, Cecilia Herraiz1,2
1Department of Biochemistry, Molecular Biology and Immunology, School of Medicine, Campus de Excelencia Internacional Regional (CEIR), Campus Mare Nostrum (CMN), University of Murcia, 30120 Murcia, Spain.
International journal of molecular sciences
|February 26, 2025
概括
一个新的4基因特征,包括MGRN1,MLANA,PMEL和TYRP1,改善了超越TNM分期的黑色素瘤风险预测. 这一发现有助于识别侵袭性黑色素瘤病例,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 皮肤黑色素瘤是最致命的皮肤癌,发病率不断增加,转移潜力高.
- 目前的瘤结节转移 (TNM) 阶段测定对中间阶段的准确性有限,错误地分类了具有侵略性疾病的患者.
- 迫切需要可靠的预后生物标志物来改善黑色素瘤风险分层.
研究的目的:
- 发现和验证皮肤黑色素瘤的新型预后生物标志物.
- 为了提高风险预测的准确性,超越现有的TNM分阶段系统.
- 确定与侵袭性黑色素瘤进展相关的分子机制.
主要方法:
- 利用TCGA-SKCM和GEO队列的基因组和临床数据来发现和验证生物标志物.
- 评估黑色素瘤驱动基因突变和过度表达的预后价值.
- 使用转录基因数据开发并验证了4个基因表达特征 (MGRN1,MLANA,PMEL,TYRP1).
- 进行了瘤的转录基因分析和MGRN1-淘汰细胞的功能分析.
主要成果:
- 主要黑色素瘤驱动基因变异没有产生显著的预后信息.
- 一个4基因签名 (MGRN1,MLANA,PMEL,TYRP1) 准确地识别了 (>80%的敏感性) 低至中级TNM阶段患者的不良结果.
- 具有这种特征的瘤显示出炎症反应,细胞循环和DNA损伤/修复途径的调节失调,这在MGRN1-淘汰细胞中得到证实.
结论:
- MGRN1-MLANA-PMEL-TYRP1基因特征增强了TNM分期,改善了黑色素瘤的预后.
- 这种生物标志物组合突显了免疫反应和基因组不稳定性在黑色素瘤进展中的作用.
- 这些发现为识别高风险黑色素瘤患者提供了更精确的工具,指导临床管理.
相关概念视频
01:16What is an ANOVA?
7.7K
The Analysis of Variance or ANOVA is a statistical test developed by Ronald Fisher in 1918. It is performed on three or more samples to check for equality between their means.
Before performing ANOVA, one must ensure that the samples used for this analysis have three crucial characteristics or statistical assumptions. The first assumption states that the samples should be drawn from normally distributed samples, while the second requires that all the drawn samples should be randomly and...
Before performing ANOVA, one must ensure that the samples used for this analysis have three crucial characteristics or statistical assumptions. The first assumption states that the samples should be drawn from normally distributed samples, while the second requires that all the drawn samples should be randomly and...
7.7K
01:18Aromatic Hydrocarbon Anions: Structural Overview
2.6K
Neutral hydrocarbons like cyclopentadiene with an odd number of carbon atoms and one intervening CH2 group in the ring are not aromatic. Cyclopentadiene with 4 π electrons does not satisfy the 4n + 2 π electron rule. Additionally, the intervening CH2 group is sp3 hybridized and lacks a vacant p orbital, thereby interrupting the overlap of p orbitals in a continuous manner and preventing the delocalization of π electrons throughout the ring.
Due to the absence of continuous...
Due to the absence of continuous...
2.6K
01:13What is ANOVA?
1.7K
The Analysis of Variance or ANOVA is a statistical test developed by Ronald Fisher in 1918. It is performed on three or more samples to check for equality between their means.
Before performing ANOVA, one must ensure that the samples used for this analysis have three crucial characteristics or statistical assumptions. The first assumption states that the samples should be drawn from normally distributed samples, while the second requires that all the drawn samples be randomly and independently...
Before performing ANOVA, one must ensure that the samples used for this analysis have three crucial characteristics or statistical assumptions. The first assumption states that the samples should be drawn from normally distributed samples, while the second requires that all the drawn samples be randomly and independently...
1.7K
01:19Anastomoses
597
In human anatomy, anastomosis refers to a connection or opening between two things, particularly between blood vessels or other tubular structures. The term is derived from the Greek term 'anastomosis,' which means 'outlet' or 'opening.' This natural network of connections plays a critical role in the survival and functionality of the human body.
Anastomoses can be formed at arterial, venous, and lymphatic vessels.
Arterial Anastomosis: These occur between arteries. They...
Anastomoses can be formed at arterial, venous, and lymphatic vessels.
Arterial Anastomosis: These occur between arteries. They...
597
01:14Agonism and Antagonism: Quantification
301
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
301
01:39Anaphase A and B
3.9K
Microtubules form through the end-to-end polymerization of tubulin heterodimers. Kinetochore microtubules originate from the spindle poles, and their plus-ends connect with the kinetochores on sister-chromatids. Ndc80 protein complexes, present on the kinetochore, form low-affinity links with the plus end of these kinetochore microtubules.
Plus-end depolymerization releases tubulin heterodimers from the terminal region of the microtubule. As tubulin subunits are lost, the Ndc80 complexes detach...
Plus-end depolymerization releases tubulin heterodimers from the terminal region of the microtubule. As tubulin subunits are lost, the Ndc80 complexes detach...
3.9K